These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32099348)

  • 1. Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD - Real-World Data from a Primary Care Setting.
    Ellingsen J; Johansson G; Larsson K; Lisspers K; Malinovschi A; Ställberg B; Thuresson M; Janson C
    Int J Chron Obstruct Pulmon Dis; 2020; 15():235-245. PubMed ID: 32099348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform.
    Schultze A; Walker AJ; MacKenna B; Morton CE; Bhaskaran K; Brown JP; Rentsch CT; Williamson E; Drysdale H; Croker R; Bacon S; Hulme W; Bates C; Curtis HJ; Mehrkar A; Evans D; Inglesby P; Cockburn J; McDonald HI; Tomlinson L; Mathur R; Wing K; Wong AYS; Forbes H; Parry J; Hester F; Harper S; Evans SJW; Quint J; Smeeth L; Douglas IJ; Goldacre B;
    Lancet Respir Med; 2020 Nov; 8(11):1106-1120. PubMed ID: 32979987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of long-acting bronchodilators and exposure to inhaled corticosteroids on mortality in COPD: a real-life retrospective cohort study.
    Manoharan A; Short PM; Anderson WJ; Lipworth BJ
    Lung; 2014 Oct; 192(5):649-52. PubMed ID: 24952426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.
    van Geffen WH; Tan DJ; Walters JA; Walters EH
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD011600. PubMed ID: 38054551
    [TBL] [Abstract][Full Text] [Related]  

  • 6.  Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study.
    Janson C; Johansson G; Ställberg B; Lisspers K; Olsson P; Keininger DL; Uhde M; Gutzwiller FS; Jörgensen L; Larsson K
    Respir Res; 2018 Sep; 19(1):172. PubMed ID: 30200965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
    COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple inhaled therapy in COPD patients: determinants of prescription in primary care.
    Vetrano DL; Zucchelli A; Bianchini E; Cricelli C; Piraino A; Zibellini M; Ricci A; Onder G; Lapi F
    Respir Med; 2019; 154():12-17. PubMed ID: 31202120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study.
    Larsson K; Janson C; Ställberg B; Lisspers K; Olsson P; Kostikas K; Gruenberger JB; Gutzwiller FS; Uhde M; Jorgensen L; Johansson G
    Int J Chron Obstruct Pulmon Dis; 2019; 14():995-1008. PubMed ID: 31190785
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework.
    Chen CY; Pan SW; Hsu CC; Liu JJ; Kumamaru H; Dong YH
    Respir Res; 2023 Sep; 24(1):239. PubMed ID: 37775734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease.
    Fukuda N; Horita N; Kaneko A; Goto A; Kaneko T; Ota E; Kew KM
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD012066. PubMed ID: 37276335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of heart failure and other comorbidities on mortality in patients with chronic obstructive pulmonary disease: a register-based, prospective cohort study.
    Kaszuba E; Odeberg H; Råstam L; Halling A
    BMC Fam Pract; 2018 Nov; 19(1):178. PubMed ID: 30474547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.
    Suissa S; Dell'Aniello S; Ernst P
    Lancet Respir Med; 2018 Nov; 6(11):855-862. PubMed ID: 30343028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study.
    Short PM; Lipworth SI; Elder DH; Schembri S; Lipworth BJ
    BMJ; 2011 May; 342():d2549. PubMed ID: 21558357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap.
    Su VY; Yang YH; Perng DW; Tsai YH; Chou KT; Su KC; Su WJ; Chen PC; Yang KY
    Aging (Albany NY); 2019 Jun; 11(11):3650-3667. PubMed ID: 31175265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.
    Quint JK; Herrett E; Bhaskaran K; Timmis A; Hemingway H; Wedzicha JA; Smeeth L
    BMJ; 2013 Nov; 347():f6650. PubMed ID: 24270505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β
    Wang MT; Lai JH; Huang YL; Liou JT; Cheng SH; Lin CW; Pan HY; Hsu YJ; Tsai CL
    Chest; 2021 Oct; 160(4):1255-1270. PubMed ID: 34023320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Ann Pharmacother; 2017 Nov; 51(11):945-953. PubMed ID: 28677404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription Patterns of New Use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids.
    Liao PA; Pan SW; Chen CY; Deng CY; Dong YH
    Int J Chron Obstruct Pulmon Dis; 2023; 18():553-563. PubMed ID: 37069844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.